Table 1 Demographic and clinical characteristics of cataract patients, N = 270
Variable | no Nd:YAG | Nd:YAG-treated | P-value |
|---|---|---|---|
(n = 235) | (n = 35) | ||
Age at surgery, median (10th-90th percentiles), N = 270 | 75 (58.6-83.0) | 71 (44.0-81.4) | 0.022* |
Female gender, n (%), N = 270 | 157 (66.8) | 24 (68.6) | 1.00† |
Pseudoexfoliations | 48 (21.7) | 9 (25.7) | 0.66† |
present preoperatively, | |||
n (%), N = 256 | |||
Uveitis diagnosis prior to cataract surgery, n (%), N = 256 | 7 (3.2) | 1 (2.9) | 1.00† |
Diabetes prior to cataract surgery, n (%), N = 255 | 17 (7.7) | 5 (14.7) | 0.188† |
Type of IOL, n (%), N = 268 | |||
- Tecnis ZA9003 | 85 (36.5) | 8 (22.9) | |
- SN60AT | 75 (32.2) | 8 (22.9) | |
- Acrysof SN60WF | 64 (27.5) | 10 (28.6) | |
- MA60MA | 1 (0.4) | 0 (0.0) | |
- Akreos Adapt | 2 (0.9) | 2 (5.7) | |
- Akreos MI60 | 4 (1.7) | 6 (17.1) | |
- Acrismart | 1 (0.4) | 0 (0.0) | |
- Hoya PY-60 AD | 1 (0.4) | 1 (2.9) | |
Additional topical | 20 (8.5) | 3 (8.6) | 1.00† |
anti-inflammatory | |||
treatment postoperatively ‡ | |||
n (%), N = 270 |